GoodRx reports that choosing the right asthma inhaler depends on symptom severity and frequency, with options for quick relief and daily control.

A new asthma drug, Lunsekimig, is showing promise in reducing inhaler dependence. Early trials report fewer symptoms, ...

A new asthma drug named Lunsekimig could be the answer for millions who remain dependent on inhalers. Here is what the phase ...

Severe Asthma Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight The severe asthma clinical trial analysis ...

Going from a medium-dose inhaled corticosteroid to a biologic for asthma led to significant decreases in exacerbations, ...

Back away from the broom. New research suggests that bringing more grime into your home might actually help your kids’ asthma ...

When it comes to blaming your health on the weather, asthma sufferers have good reason when a thunderstorm rolls into town.

Sanofi posts strong mid-stage results for lunsekimig in asthma and CRSwNP but a setback in atopic dermatitis clouds the ...

People suffering from asthma, performing specific asanas can make a noticeable difference, building resilience without ...

Seasonal changes can worsen asthma and allergies due to triggers like pollen, pollution and humidity. A doctor explains how ...

Sanofi says lunsekimig hit Phase 2 endpoints in asthma and CRSwNP, showing dual TSLP/IL-13 blockade and solid safety—read ...

The 2026 World Press Photo Contest documents our fragility, resiliency, and the best and worst of humanity. More than 3,700 ...